These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33533399)

  • 21. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
    Bioque M; Llerena A; Cabrera B; Mezquida G; Lobo A; González-Pinto A; Díaz-Caneja CM; Corripio I; Aguilar EJ; Bulbena A; Castro-Fornieles J; Vieta E; Lafuente A; Mas S; Parellada M; Saiz-Ruiz J; Cuesta MJ; Bernardo M;
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26506856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication, hospitalizations and mortality in 5 years after first-episode psychosis in a Swedish nation-wide cohort.
    Strålin P; Hetta J
    Early Interv Psychiatry; 2019 Aug; 13(4):902-907. PubMed ID: 29888512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective naturalistic study on the psychopharmacological treatment of schizoaffective disorder.
    Muñoz-Negro JE; Aguado Bailón L; Calvo Rivera P; Cervilla JA
    Int Clin Psychopharmacol; 2021 Sep; 36(5):257-263. PubMed ID: 34270506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study.
    Lähteenvuo M; Paljärvi T; Tanskanen A; Taipale H; Tiihonen J
    Br J Psychiatry; 2023 Oct; 223(4):456-464. PubMed ID: 37395140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.
    Tiihonen J; Wahlbeck K; Lönnqvist J; Klaukka T; Ioannidis JP; Volavka J; Haukka J
    BMJ; 2006 Jul; 333(7561):224. PubMed ID: 16825203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Danileviciūte V
    Medicina (Kaunas); 2002; 38(11):1057-65. PubMed ID: 12532717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.
    Bodén R; Brandt L; Kieler H; Andersen M; Reutfors J
    Schizophr Res; 2011 Dec; 133(1-3):36-41. PubMed ID: 21982098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis).
    Zhang T; Xu L; Tang X; Wei Y; Hu Q; Hu Y; Cui H; Tang Y; Hui L; Li C; Cao L; Lu Z; Wang J
    Aust N Z J Psychiatry; 2020 Jul; 54(7):696-706. PubMed ID: 32436725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New developments in the pharmacologic treatment of schizoaffective disorder.
    Keck PE; McElroy SL; Strakowski SM
    J Clin Psychiatry; 1996; 57 Suppl 9():41-8. PubMed ID: 8823349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.
    Advokat C; Dixon D; Schneider J; Comaty JE
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):487-95. PubMed ID: 15093956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder.
    Brand BA; Sommer IE; Gangadin SS; Tanskanen A; Tiihonen J; Taipale H
    Am J Psychiatry; 2024 Oct; 181(10):893-900. PubMed ID: 39262210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study.
    Rubio JM; Taipale H; Correll CU; Tanskanen A; Kane JM; Tiihonen J
    Psychol Med; 2020 Jun; 50(8):1356-1367. PubMed ID: 31190660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis.
    Solmi M; Taipale H; Holm M; Tanskanen A; Mittendorfer-Rutz E; Correll CU; Tiihonen J
    Am J Psychiatry; 2022 Dec; 179(12):938-946. PubMed ID: 36200276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
    Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
    Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
    Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
    J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.